Showing results (1-10 of 230) with videos related to
Sort By:
Pageof 23
The Medical Journal of Australia|May 20, 1996
Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory CommitteeP McManus, J G Primrose, D A Henry, et al.Clinical and Experimental Pharmacology & Physiology|June 1, 1989
Racemates or enantiomers: regulatory approachesD J BirkettAustralian Family Physician|March 1, 1980
The practical application of drug assays in general practiceD J BirkettBritish Journal of Clinical Pharmacology|October 1, 1995
Modelling the market uptake of new drugs following listing for subsidy in Australia. A report from the Drug Utilisation Subcommittee of the Australian Pharmaceutical Benefits Advisory CommitteeD J Birkett, P McManusBiochimica Et Biophysica Acta|December 20, 1982
The effects of N-B transition of human serum albumin on the specific drug-binding sitesS Wanwimolruk, D J BirkettClinica Chimica Acta; International Journal of Clinical Chemistry|September 6, 1976
The interactions between iophenoxic acid, iopanoic acid, bilirubin and human serum albumin as studied by fluorescence and Sephadex gel filtrationD J Birkett, J KapitulnikBritish Journal of Clinical Pharmacology|July 15, 1998
Cytochrome P4502C9: an enzyme of major importance in human drug metabolismJ O Miners, D J BirkettGeneral Pharmacology|March 1, 1996
The use of caffeine as a metabolic probe for human drug metabolizing enzymesJ O Miners, D J BirkettBritish Journal of Clinical Pharmacology|April 1, 1991
Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports eventsD J Birkett, J O MinersClinical Pharmacology and Therapeutics|October 1, 1981
Cigarette smoking and theophylline clearance and metabolismJ J Grygiel, D J BirkettPageof 23